Ayse Nuransoy Cengiz

6PUBLICATIONS
64CO-AUTHORS
Nutrigenomics and personalised nutritionCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 20, 2026
The role of the prognostic nutritional index at baseline and follow-up in patients with metastatic prostate cancer.

|Jul 28, 2026
Comparison of Neoadjuvant TCHP and ddAC+THP Regimens for Pathologic Complete Response in HER2-Positive Breast Cancer: A Multicenter Real-World Analysis of Systemic Inflammatory Biomarkers.

|May 08, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

|Apr 14, 2026
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

|Feb 21, 2026
The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer.

Muhammet Cengiz, Oktay Bozkurt, Ayşe Nuransoy Cengiz

|Jul 31, 2025
Alamandine: Protective Effects Against Renal Ischemia-Reperfusion Injury-Induced Renal and Liver Damage in Diabetic Rats.

Ayse Nuransoy Cengiz, Onural Ozhan, Lokman Hekim Tanriverdi

Pageof 1

Frequent Collaborators

4 joint publications

Deniz Can Guven

4 joint publications

Emel Mutlu Ozkan

4 joint publications

Oktay Bozkurt

4 joint publications

Metin Ozkan